{
  "@context": {
    "bsc": "http://bioschemas.org/",
    "edam": "http://edamontology.org/",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://bio.tools/ADPedKD",
      "@type": "sc:SoftwareApplication",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_3384"
        },
        {
          "@id": "edam:topic_3422"
        },
        {
          "@id": "edam:topic_3418"
        }
      ],
      "sc:citation": [
        "pmcid:PMC6732756",
        "pubmed:31517146",
        {
          "@id": "https://doi.org/10.1016/J.EKIR.2019.05.015"
        }
      ],
      "sc:description": "> CORRECT NAME OF TOOL COULD ALSO BE 'ADPKD' | A Global Online Platform on the Management of Children With ADPKD | Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common monogenic cause of kidney failure, affecting more than 1 in 400 to 1000 live births and approximately 13 million individuals worldwide, representing a major socio-economic medical problem in the world | Currently, there is no definitive curative treatment | ADPedKD, initiated by Djalila Mekahli (Leuven, Belgium) and Max Liebau (Cologne, Germany), is a international, longitudinal registry including ADPKD patients followed up from childhood",
      "sc:featureList": {
        "@id": "edam:operation_3557"
      },
      "sc:name": "ADPedKD",
      "sc:url": "https://www.adpedkd.org/"
    },
    {
      "@id": "https://doi.org/10.1016/J.EKIR.2019.05.015",
      "@type": "sc:CreativeWork"
    }
  ]
}